Skip to content

JMEDIC: what changed

BE 0792.345.587NACE 86.210, General medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€114,039
2024 · €113,085+€954
Equity
€330,792
2024 · €216,753+€114,039
Cash
€253,042
2024 · €175,260+€77,783
Balance sheet total
€342,930
2024 · €229,807+€113,122

Largest movements

2024 to 2025
Assets
  • Cash +€77,783

    up €77,783 (+44.4%), from €175,260 to €253,042

    mainly Net result for the year (+€114,039) and Depreciation (+€1,082)

  • Current investments +€19,862

    first reported in 2025, at €19,862

  • Receivables within one year +€15,785

    up €15,785 (+36.1%), from €43,768 to €59,553

    of which Other amounts receivable: +€16,520

Equity and liabilities
  • Reserves +€114,039

    up €114,039 (+52.9%), from €215,753 to €329,792

Income statement
  • Financial income +€1,710

    up €1,710 (+165%), from €1,036 to €2,746

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €113,085
Gross operating margin +€120
Depreciation -€135
Financial income +€1,710
Financial charges +€104
Taxes -€845
Result 2025 €114,039
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€98,558
Investment -€20,775
Financing €0
Cash 2024 €175,260
Net result for the year +€114,039
Depreciation +€1,082
Receivables within one year -€15,785
Smaller working-capital items +€235
Trade debts -€1,012
Investment in fixed assets (net) -€913
Current investments -€19,862
Cash 2025 €253,042
brings cash intakes cash out
Every line side by side 34 lines
Line Code 2024 2025 Change %
Total assets 20/58 €229,807 €342,930 +€113,122 +49.2%
Fixed assets 21/28 €4,073 €3,904 -€169 -4.1%
Tangible fixed assets 22/27 €4,073 €3,904 -€169 -4.1%
Furniture and vehicles 24 €2,931 €2,884 -€47 -1.6%
Other tangible fixed assets 26 €1,142 €1,020 -€122 -10.7%
Current assets 29/58 €225,734 €339,026 +€113,291 +50.2%
Amounts receivable within one year 40/41 €43,768 €59,553 +€15,785 +36.1%
Trade receivables 40 €735 - -€735
Other amounts receivable 41 €43,033 €59,553 +€16,520 +38.4%
Current investments 50/53 - €19,862 +€19,862
Cash at bank and in hand 54/58 €175,260 €253,042 +€77,783 +44.4%
Deferred charges and accrued income 490/1 €6,707 €6,568 -€139 -2.1%
Total equity and liabilities 10/49 €229,807 €342,930 +€113,122 +49.2%
Equity 10/15 €216,753 €330,792 +€114,039 +52.6%
Contributions 10/11 €1,000 €1,000 = 0.0%
Reserves 13 €215,753 €329,792 +€114,039 +52.9%
Distributable reserves 133 €215,753 €329,792 +€114,039 +52.9%
Amounts payable 17/49 €13,054 €12,138 -€917 -7.0%
Amounts payable within one year 42/48 €13,054 €12,138 -€917 -7.0%
Trade debts 44 €1,746 €734 -€1,012 -58.0%
Suppliers 440/4 €1,746 €734 -€1,012 -58.0%
Taxes, remuneration and social security 45 €11,309 €11,404 +€95 +0.8%
Taxes 450/3 €11,309 €11,404 +€95 +0.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €947 €1,082 +€135 +14.2%
Gross operating margin 9900 €161,404 €161,524 +€120 +0.1%
Operating profit (loss) 9901 €160,457 €160,442 -€15 0.0%
Financial income 75/76B €1,036 €2,746 +€1,710 +165%
Recurring financial income 75 €1,036 €2,746 +€1,710 +165%
Financial charges 65/66B €870 €766 -€104 -12.0%
Recurring financial charges 65 €870 €766 -€104 -12.0%
Profit (loss) for the period before taxes 9903 €160,622 €162,422 +€1,799 +1.1%
Income taxes 67/77 €47,537 €48,382 +€845 +1.8%
Profit (loss) for the period 9904 €113,085 €114,039 +€954 +0.8%
Profit (loss) for the period to be appropriated 9905 €113,085 €114,039 +€954 +0.8%

Value

latest balance sheet 30-06-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€558,007 to €715,051

Midpoint €623,442 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €330,792
Capitalised earnings €785,221 to €1.1m
Indication €558,007 to €715,051

Adjusted equity

balance sheet 30-06-2025
Equity (10/15)
€330,792
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€330,792

Capitalised earnings

net result for the year (9904)
2025
€114,039
2024
€113,085
2023
€102,668
Average result
€109,931
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€785,221 / €916,092 / €1.1m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 30 June 2024 and 30 June 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 17 November 2026 via checked.be.